Transfusion Medicine
1 – 10 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Characterization of GYP*Mur and novel GYP*Bun-like hybrids in Thai blood donors reveals a qualitatively altered s antigen
Jongruamklang, Philaiphon LU ; Grimsley, Shane ; Thornton, Nicole ; Robb, Janine ; Olsson, Martin L. LU
and
Storry, Jill R.
LU
(2020)
In Vox Sanguinis
Mark
- May the FORS be with you : a system sequel
-
SMIM1, carrier of the Vel blood group, is a tail-anchored transmembrane protein and readily forms homodimers in a cell-free system
Nylander, Anja LU
;
Leznicki, Pawel
;
Vidovic, Karina
LU
;
High, Stephen
and
Olsson, Martin L.
LU
(2020)
In Bioscience Reports
40(5).
Mark
-
Human radical scavenger α1-microglobulin protects against hemolysis in vitro and α1-microglobulin knockout mice exhibit a macrocytic anemia phenotype
Kristiansson, Amanda LU ; Bergwik, Jesper LU ; Alattar, Abdul Ghani LU
;
Flygare, Johan
LU
;
Gram, Magnus
LU
;
Hansson, Stefan R
LU
;
Olsson, Martin L
LU
;
Storry, Jill R
LU
;
Allhorn, Maria
LU
and
Åkerström, Bo
LU
(2020)
In Free Radical Biology & Medicine
Mark
- External quality assessment of noninvasive fetal RHD genotyping
-
The Xg blood group system : no longer forgotten
Lee, Yan Q. LU ; Storry, Jill R. LU and Olsson, Martin L. LU
(2020)
In Immunohematology
36(1).
p.4-6
Mark
- 2019
-
A large deletion spanning XG and GYG2 constitutes a genetic basis of the Xgnull phenotype, underlying anti-Xga production
Lee, Yan Quan LU ; Storry, Jill R LU ; Karamatic Crew, Vanja ; Halverson, Gregory R ; Thornton, Nicole and Olsson, Martin L LU
(2019)
In Transfusion
59(5).
p.1843-1849
Mark
- Towards universally acceptable blood
-
A novel single-nucleotide substitution in the proximal ABO promoter gives rise to the B3 phenotype
Hellberg, åsa LU ; Hult, Annika K. LU ; Moser, Ines ; Tomaz, Beatriz ; Rodrigues, Maria and Olsson, Martin L. LU
(2019)
In Transfusion
59(10).
p.1-3
Mark
- Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis–an external quality assessment workshop